Nurix Therapeutics, Inc. (NASDAQ:NRIX) appears in 179 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 2,112,608 | 31.24% | $0.00 |
| Redmile Group, LLC | 31 Dec, 2025 | 0 | 4,415,514 | 120.04% | $0.00 |
| Deep Track Capital, LP | 31 Dec, 2025 | 0 | 979,431 | 16.17% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -116,755 | -31.26% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 1,460,736 | 32.54% | $0.00 |
| Vestal Point Capital, LP | 31 Dec, 2025 | 0 | 1,215,000 | 34.96% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 2,136 | 0.00% | $0.00 |
| GENERAL ATLANTIC, L.P. | 31 Dec, 2025 | 0 | 4,897,159 | 0.00% | $0.00 |
| Pictet Asset Management Holding SA | 31 Dec, 2025 | 0 | 1,487,060 | 75.08% | $0.00 |
| Morgan Stanley | 31 Dec, 2025 | 0 | 2,620,323 | 115.91% | $0.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 0 | 340,183 | 11.85% | $0.00 |
| BAKER BROS. ADVISORS LP | 31 Dec, 2025 | 0 | 776,431 | 20.00% | $0.00 |
| Rubric Capital Management LP | 31 Dec, 2025 | 0 | 2,473,885 | 0.00% | $0.00 |
| FMR LLC | 31 Dec, 2025 | 0 | -4,653,379 | -52.36% | $0.00 |
| Commodore Capital LP | 31 Dec, 2025 | 0 | -1,505,055 | -39.82% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 697,114 | 24.35% | $0.00 |
| BRAIDWELL LP | 31 Dec, 2025 | 0 | 2,183,864 | 0.00% | $0.00 |
| PERCEPTIVE ADVISORS LLC | 31 Dec, 2025 | 0 | 2,139,728 | 151.09% | $0.00 |
| Kynam Capital Management, LP | 31 Dec, 2025 | 0 | -198,248 | -9.14% | $0.00 |
| DEUTSCHE BANK AG\ | 31 Dec, 2025 | 0 | 1,047,933 | 72.83% | $0.00 |